Spina Bifida: Prevalence, Gender Differences, and Key Facts
Spina bifida is a neural tube defect occurring when the spinal column fails to close completely during early embryonic development (days 21–28 post-conception).
Epidemiology
- Incidence: ~1 in 2,500 live births globally (varies by region and folate fortification).
- Gender ratio: Females affected more often than males (~1.2–1.5:1, not 2:1 as sometimes cited).
- Timing: Present at birth; not acquired later in life.
- Types: Occulta (mild, often asymptomatic), meningocele, myelomeningocele (most severe, open defect with neural tissue exposure).
Risk Factors
- Maternal folate deficiency (primary preventable cause)
- Certain antiseizure medications (valproate, carbamazepine)
- Maternal diabetes, obesity
- Family history (recurrence risk ~3–5% after one affected child)
- Genetic variants in folate pathway genes (MTHFR)
Prevention and Care
- Folic acid supplementation (400–800 mcg daily) before conception and in early pregnancy reduces risk by ~70%.
- Prenatal screening (maternal serum AFP, ultrasound) enables early detection.
- Multidisciplinary lifelong care: neurosurgery, urology, orthopedics, physiatry, neuropsychology.
Genetic Disorders - Related Articles
- Sickle Cell Disease: Genetics, Inheritance, and Population Distribution
- Disease Prevention: Impact on Development and Economic Growth
- Recognizing Signs of Abnormal Behavior: A Clinical Guide
- Understanding Lipid Metabolism Disorders: Causes, Symptoms & Management
- Embryonic Stem Cell Research: Benefits and Ethical Considerations
- Genomic Testing 101: Types, Benefits, Limitations, and What to Expect
- Understanding and Diagnosing Triple X Syndrome: Symptoms & Testing
